Trump's Drug Pricing Speech Mostly Hit the Right Notes


By Sally C. Pipes

President Trump delivered a major speech from the White House Rose Garden on prescription drug prices this spring. He announced several policies aimed at reducing the overall cost of pharmaceuticals and limiting patients' out-of-pocket expenses.

His reform agenda, entitled "American Patients First," is largely excellent. It mostly harnesses the power of free-market competition, rather than government price controls, to drive down costs for patients while continuing to incentivize drug manufacturers to invest in innovative, lifesaving research.

Contrary to popular belief, drug spending has been relatively flat. It rose just 0.6 percent in 2017—significantly lower than the overall rate of inflation. Per-patient prescription spending actually decreased 2.2 percent. Powerful middlemen known as pharmacy benefit managers (PBMs) are to blame for those rising costs.

PBMs negotiate drug prices on behalf of insurance plans. These middlemen also determine which drugs insurers will cover and the levels of co-payment and co-insurance. PBMs use their enormous negotiating leverage to extract big concessions from manufacturers. Pharmaceutical companies give 37 percent of drugs' list prices back to PBMs, insurers, and other middlemen via rebates and discounts. These rebates are often paid to PBMs weeks after a transaction occurs at a pharmacy—and add up to more than $100 billion annually.

Patients rarely get a share of that 12-figure sum. PBMs and insurers keep nearly 90 percent of the rebates they receive from drug companies.

President Trump has pledged to fix this imbalance. He is calling on the Department of Health and Human Services to require PBMs to better disclose these rebates—and to pass at least one-third of the savings to patients. Lower out-of-pocket costs lead to higher rates of adherence to medication —and better health outcomes.

President Trump has also promised to crack down on foreign countries that freeload off American research and development spending on pharmaceuticals. Right now, many countries artificially cap the price of drugs. And they impose trade barriers that force American drug manufacturers to sell their products at steep discounts. Such practices shift the burden of funding drug development onto American patients and taxpayers. Seventy percent of pharmaceutical companies' global profits come from sales made in the United States.

Unfortunately, the president's speech did contain one proposal antithetical to market principles. The administration hopes to cap future price increases for drugs dispensed under Medicare Part B at the rate of inflation. Part B pays for potent drugs, such as chemotherapy, that must be administered with a doctor's supervision.

Artificially capping Part B drug spending—which comprises just 3 percent of total Medicare spending—could discourage manufacturers from investing in new research projects. It is encouraging that President Trump did not call for the federal government to negotiate drug prices for the successful Medicare Part D drug program.

The data show that America's prescription drug tab is rising at a rate lower than inflation—even as the companies who make those drugs are investing ever-more money in research and development. But there are certainly ways to drive drug prices lower—and incentivize even more research. By moving to restrain the power of pharmacy benefit managers and crack down on unfair foreign trade barriers, the Trump administration appears to understand as much.

Sally C. Pipes is president, CEO, and Thomas W. Smith Fellow in Health Care Policy at the Pacific Research Institute. Her latest book is The False Promise of Single-Payer Health Care (Encounter). Follow her on Twitter @sallypipes.

More Resources


03/29/2024
Behind Scenes Stories of Censorship


more info


03/29/2024
Where RFK Jr. Goes From Here


more info


03/29/2024
Will the RFK Factor Make a Difference in 2024?
Robert Kennedy Jr. leads the highest-polling independent presidential ticket in over 30 years

more info


03/29/2024
Democrats May Keep the Senate--With a Little GOP Help
The inexplicable determination of the party's voters to pick unstable provocateurs might be the only path Democrats have to hanging onto their narrow and very much endangered Senate majority.

more info


03/29/2024
You Count Votes Over and Over Until They Add Up Right
By John Kass March 27, 2024 Illinois Gov. J.B. Pritzker-the perpetually frightened rich kid born on third base thinking he hit a triple-has a big fat political problem. He's hosting the Democratic National Convention, his big fat coming out party in Chicago, in August. His fantasy? Becoming president of the United States of America. As he's planning his party, America ... Read More

more info


03/29/2024
The Long Road Back for the Port of Baltimore
For the moment, Maryland officials are focused on crisis management.

more info


03/29/2024
Enough Already
City leaders keep searching for the root cause of crime-they should look in the mirror.

more info


03/28/2024
The Democrats' Abundance Problem Revisited
Last week, I started revisiting my "Three Point Plan to Fix the Democrats and Their Coalition" from October of 2022. A brisk tour of the polling and political data suggested the Democrats are still in need of serious reform and that the three point plan is as relevant as ever. Here's the very short version of the plan:

more info


03/28/2024
Are Democrats Still Stuck With Biden?
Voters don't think much of the president but also remain wary of the obvious replacement.

more info


03/28/2024
What the Polls Say: RFK Jr. Hurting Biden, Helping Trump
In October, when Robert F. Kennedy Jr. abandoned his primary challenge to Joe Biden and instead launched an independent candidacy, the initial conventional wisdom was that he might hurt Donald Trump more than Biden.

more info


03/28/2024
The Twilight of the Republican 'McLeadership'
The Trump team is steadily purging the Republican leadership of holdovers from past decades. The departure of McCarthy, McDaniel, and McConnell is part of exorcising the legacy of a more important Mc whose influence is still felt in the U.S. Senate: John McCain.

more info


03/28/2024
The Funniest Media Story of the Year?
The following three things were obvious before MSNBC puked on itself in its public divorce with former RNC chief Ronna McDaniel, but aren't we glad the network didn't notice? More later, but briefly:

more info


03/28/2024
Abridging, Not Coercing, Is First Amendment's Yardstick
Under the First Amendment, the government may not abridge the freedom of speech, whether that abridging is done by coercing internet platforms or by getting them to cooperate in government efforts to censor the public.

more info


03/28/2024
Trade Cheaters Are Killing Aluminum Industry Jobs
Aluminum industry workers stand ready to do their part to move the nation forward. They just need the federal government to enforce trade laws.

more info


03/28/2024
It's Time for an Immigration Moratorium
An effective freeze on immigration could revitalize our national culture, politics, and economy before it's too late.

more info



Custom Search

More Politics Articles:

Related Articles

The Interational Fix to Rural America's Healthcare Crisis


Imagine going into cardiac arrest and the closest emergency room is more than 30 miles away. Or suppose your child is struggling with depression, but there isn't a single psychiatrist in your county. Or consider experiencing unexpected pregnancy complications -- yet living hours away from a hospital that has the resources to help.

We Need Health Care Reforms That Help Patients, Families


This summer, we saw remarkable, bipartisan progress on addressing rising health care costs -- an issue voters have consistently ranked as most important.

The Strategic Effect of Operation Kayla


Raids, like Operation Kayla resulting in the death of Abu-Bakr al-Baghdadi and other ISIS terrorist leaders, are usually small affairs with limited results. Nevertheless, such meticulously planned and superbly executed raids also can have significant strategic implications.

Save the Electoral College: The Founders Warned of an "'Overbearing Majority"


An apparent new litmus test has appeared among the 2020 Democratic presidential hopefuls: abolishing the Electoral College.

A Lot Less Bluster and a Little More Sasse


Predictably, the start of Brett Kavanaugh's confirmation hearing to the Supreme Court was an embarrassing fiasco for almost everyone involved. The Republican chair of the Judiciary Committee, Senator Chuck Grassley, had barely begun his opening remarks before Democratic Senator Kamala Harris interrupted to demand the meeting be adjourned, and less than two minutes in protestors started screaming. Protestors continued to interrupt the hearing, which was mostly just senatorial demagoguery on camera anyway, for the next four hours or so. There are many reasons for this: the stakes are high, everything connected with President Trump is radioactive, and the midterms are just two months away. But hours into a series of diatribes from senators on both sides of the aisle, Senator Ben Sasse from Nebraska took a different approach.

Pelosi's Drug Scheme Robs Patients of Tomorrow's New Medicines


The House of Representatives passed Speaker Nancy Pelosi's unprecedented crackdown on the pharmaceutical industry. Her bill, "H.R.3," would allow the government to dictate prices on a broad array of drugs, with the promise of bringing domestic prices closer to those in foreign countries with government-run healthcare systems.

The High Cost of the White House's Drug Pricing Plan


The Trump administration will soon roll out a new plan to slash drug prices.

Are You Tired of Watching America's Natural Landscapes Disappear?


America's population is soaring. Our nation currently houses 330 million people. And each year, that number grows by 2 million. By 2065, more than 440 million people may call the United States home.

End Foreign Freeloading - Don't Import It


Since day one in office, President Trump has been eager to put America first -- even when it has meant upending norms, upsetting political allies, and straining relationships abroad. This eagerness is worth applauding.

Correcting This Faulty Belief About COVID-19 Will Save Lives


In times of emergency, misperceptions can prove deadly. That's certainly the case today, amid widespread belief that COVID-19 mainly threatens older Americans.

Congress Plans to Steal the Coronavirus Vaccine


Lawmakers in Washington want to confiscate the patents on coronavirus treatments and vaccines -- before biotech companies even finish developing them.

We Don't Need an Economic Collapse to Curb Emissions
COVID-19 has caused a worldwide economic collapse. Yet some radical environmentalists are celebrating.

A Little-Known Law Gave Birth to Google -- and Countless Other Inventions


When Google founders Larry Page and Sergey Brin spoke to my colleagues at Stanford's technology licensing office in the late 1990s, other search engines already existed.

Whose Life Doesn't Matter?


I understand and affirm that black lives matter. Some of my dearest friends are black people. I love them and they matter. There are many black people, who I do not know, but they matter just the same.

Trump Administration Ends Pharmacy Coupons When Patients Need Them Most


For chronically ill Americans, the economic damage from COVID-19 could be nearly as life-threatening as the virus itself. More than 40 million workers have filed for unemployment since the beginning of the outbreak. For many, the financial challenges of joblessness have made it harder than ever to afford their insurance companies' medication copays.